Three peptides, one protocol.
GLOW is a three-peptide blend combining TB-500, BPC-157, and GHK-Cu in a single vial at 70 mg total*. The rationale is straightforward: layer a systemic recovery signal (TB-500), a local repair signal (BPC-157), and a dermal fibroblast activator (GHK-Cu) into one reconstitution.
Preclinical research on each component has been conducted independently. The blend is intended to simplify protocols where operators would otherwise rotate three separate vials* through three separate injection schedules.
Because the three peptides address different tissue layers — connective, vascular, and dermal — GLOW is often chosen by users whose goal is whole-system repair* rather than a single-site intervention.
Every lot ships with an independent Certificate of Analysis on file. Below is the format your lot's COA arrives in — HPLC chromatogram, identity, endotoxin, the works. Request the document for the exact lot you receive.
request your lot's coa →“Three peptides in one vial means one reconstitution instead of three — that alone justified the price. Lot label, COA, and packaging all consistent with my previous orders.”
“The blend pricing is more reasonable than buying GHK-Cu, BPC-157, and TB-500 individually. COA was provided for the blend and for each component peptide on request — that level of detail is unusual.”
“Repeat customer here. Subscription was easy to set up and easy to cancel before my next renewal. Vial quality is consistent across batches.”
reviews describe product + service only — purity, packaging, lot traceability, fulfilment, COA access. per health canada guidance, claims about diagnosis, treatment, or specific outcomes are edited out before publication.
Research use only. Not for human consumption. Not approved by Health Canada for therapeutic use.

The copper peptide that declines with age.

GLOW + KPV. Anti-inflammatory boost.